Northwire Canada EditionTuesday, July 14, 2026
Northwire
W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0% W 0.500 +1.0% RDG 0.160 +0.0% ARIC 0.780 +4.0% VROY 3.44 +5.2% ROCK 3.81 +3.0% APMI 0.120 +0.0% EM 3.58 −4.8% ALS 66.04 +6.8% MEK 0.065 +44.4% TLO 6.00 +13.0% ADE 0.045 −66.7% FAIR 0.060 +33.3% SVRS 0.420 −2.3% RES 0.050 +42.9% CYG 0.120 +0.0%
Earnings

KP Tissue to release Q3 2025 results Nov. 13

KPT · Price

Executive Summary

  • KP Tissue Inc. will disclose its own Q3 2025 financial results and those of its 12.2% equity investment, Kruger Products Inc., on Thursday, November 13, 2025 before the market opens.
  • A conference call for investors will be held the same day at 8:30 a.m. Eastern Time, with telephone and web access details provided.
  • The call’s audio/video rebroadcast will be available until midnight on November 20, 2025 via dedicated dial‑in numbers and pass code; webcast replay will also remain online through that date.

Key Details

  • Release Timing: Thursday, Nov 13 2025, pre‑market.
  • Conference Call: 8:30 a.m. ET, same day as release.
  • Dial‑in Numbers: 1‑888‑699‑1199 or 416‑945‑7677 (live); rebroadcast on 1‑888‑660‑6345 or 289‑819‑1450 with pass code 86584.
  • Web Access: Call and presentation materials hosted on the KP Tissue website; webcast replay available until midnight Nov 20 2025.
  • KP Tissue Ownership: Holds a 12.2% equity interest in Kruger Products, accounted for on an equity‑method basis.

Notable Quotes

(No executive quotes were included in the release.)

Read the original news release →

More from KP Tissue Inc